What Is 3-methylcrotonyl-CoA carboxylase
Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.
Last updated: April 15, 2026
Key Facts
- 3-Methylcrotonyl-CoA carboxylase deficiency occurs in about 1 in 50,000 newborns.
- The enzyme is encoded by the MCCC1 and MCCC2 genes located on chromosomes 3 and 5.
- MCC deficiency was first described in 1980 by researchers in Germany.
- Over 100 pathogenic variants in MCCC1 and MCCC2 have been linked to MCC deficiency.
- Newborn screening programs in over 30 U.S. states include testing for MCC deficiency.
Overview
3-Methylcrotonyl-CoA carboxylase (MCC) is a biotin-dependent mitochondrial enzyme essential for the catabolism of the amino acid leucine. It functions in the fourth step of leucine degradation, ensuring toxic intermediates do not accumulate in cells.
The enzyme complex is composed of two subunits encoded by separate genes, and its proper function is critical for energy production and metabolic stability. Deficiencies can lead to organic acidemias with neurological and muscular complications.
- MCC enzyme: Catalyzes the ATP-dependent carboxylation of 3-methylcrotonyl-CoA to form 3-methylglutaconyl-CoA, a key step in leucine breakdown.
- Gene locations: The MCCC1 gene is on chromosome 3q27.1, while MCCC2 is on 5q12.1, both vital for enzyme assembly.
- Enzyme structure: MCC functions as a heteromeric complex with α-subunits (MCCC1) and β-subunits (MCCC2) forming an active dimer.
- Biotin dependence: MCC requires biotin as a cofactor, which is covalently attached to the enzyme via holocarboxylase synthetase.
- Metabolic pathway: MCC operates in the mitochondrial matrix, linking amino acid metabolism to the tricarboxylic acid (TCA) cycle through acetyl-CoA production.
How It Works
The enzymatic activity of MCC involves precise molecular interactions that convert a toxic intermediate into a usable metabolic product. Each component plays a defined role in substrate binding, carboxylation, and energy utilization.
- Substrate binding: 3-Methylcrotonyl-CoA binds to the α-subunit, positioning it for carboxylation with high specificity.
- Carboxylation reaction: Biotin, activated by ATP, transfers a carboxyl group (-COOH) to the substrate in a two-step enzymatic process.
- ATP utilization: The reaction consumes one ATP molecule per turnover, providing energy for carboxyl group activation.
- Product formation: The resulting 3-methylglutaconyl-CoA is further metabolized to acetoacetate and acetyl-CoA for energy production.
- Enzyme regulation: MCC activity is modulated by acetyl-CoA levels and mitochondrial energy status to prevent metabolic overload.
- Deficiency impact: Mutations in MCCC1 or MCCC2 cause 3-methylcrotonyl-CoA carboxylase deficiency, leading to organic acid accumulation.
Comparison at a Glance
Below is a comparison of MCC with other biotin-dependent carboxylases involved in human metabolism:
| Enzyme | Substrate | Gene(s) | Associated Disorder | Incidence |
|---|---|---|---|---|
| 3-Methylcrotonyl-CoA carboxylase | 3-Methylcrotonyl-CoA | MCCC1, MCCC2 | MCC deficiency | 1 in 50,000 |
| Propionyl-CoA carboxylase | Propionyl-CoA | PCCA, PCCB | Propionic acidemia | 1 in 100,000 |
| Methylmalonyl-CoA carboxylase | Methylmalonyl-CoA | MUT | Methylmalonic acidemia | 1 in 80,000 |
| Pyruvate carboxylase | Pyruvate | PC | Pyruvate carboxylase deficiency | 1 in 250,000 |
| Acetyl-CoA carboxylase | Acetyl-CoA | ACACA, ACACB | Not typically associated with inherited disease | N/A |
These enzymes illustrate the diversity of biotin-dependent metabolism. While all require biotin, their substrates, genetic causes, and clinical impacts vary significantly, with MCC deficiency being among the more commonly detected in newborn screening.
Why It Matters
Understanding MCC function and deficiency has significant implications for diagnosis, treatment, and genetic counseling in metabolic medicine. Early detection can prevent life-threatening metabolic crises.
- Newborn screening: MCC deficiency is included in expanded tandem mass spectrometry panels used in over 30 U.S. states.
- Clinical symptoms: Untreated cases may present with hypotonia, seizures, and metabolic acidosis during catabolic stress.
- Treatment approach: Management includes low-leucine diet and supplementation with glycine and carnitine to enhance detoxification.
- Prognosis: With early intervention, most patients have normal cognitive development and avoid major complications.
- Genetic counseling: Inherited in an autosomal recessive pattern, siblings have a 25% recurrence risk.
- Research impact: MCC studies contribute to understanding mitochondrial metabolism and biotin enzyme regulation in rare diseases.
Continued research into MCC and related enzymes enhances our ability to diagnose and manage inborn errors of metabolism, improving outcomes for affected individuals worldwide.
More What Is in Daily Life
Also in Daily Life
More "What Is" Questions
Trending on WhatAnswers
Browse by Topic
Browse by Question Type
Sources
- WikipediaCC-BY-SA-4.0
Missing an answer?
Suggest a question and we'll generate an answer for it.